US2008020026A1PendingUtilityA1

Hemostatic compositions and methods for controlling bleeding

Assignee: CROSSLINK D INCPriority: Dec 31, 2001Filed: Aug 6, 2007Published: Jan 24, 2008
Est. expiryDec 31, 2021(expired)· nominal 20-yr term from priority
A61P 7/04A61L 33/08A61L 2300/418A61L 15/44A61L 2400/04A61L 15/28A61L 2300/232A61L 15/225
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides hemostatic compositions useful to promote hemostasis at active bleeding wound sites. The hemostatic compositions typically include an article containing cellulose, e.g., cotton gauze, and a polysaccharide covalently linked to the cellulose, or a polysaccharide ionically cross-linked and in association with the article. Methods of making and using the hemostatic compositions are also provided.

Claims

exact text as granted — not AI-modified
1 . A method for controlling bleeding at an active bleeding wound site of an mammal, said method comprising applying a hemostatic composition to said active bleeding wound site, said hemostatic composition comprising an article comprising cellulose and a polysaccharide covalently linked to said cellulose.  
   
   
       2 . The method of  claim 1 , wherein said polysaccharide is selected from the group consisting of cross-linked dextran, cross-linked starch, and cross-linked alginate.  
   
   
       3 . The method of  claim 2 , wherein said polysaccharide is cross-linked dextran.  
   
   
       4 . The method of  claim 2 , wherein the molecular weight of said cross-linked dextran is from about 10,000 to about 2,000,000.  
   
   
       5 . The method of  claim 4 , wherein the molecular weight of said cross-linked dextran ranges from about 20,000 to about 100,000.  
   
   
       6 . The method of  claim 1 , wherein said covalently linked polysaccharide has a molecular weight exclusion limit greater than about 30,000 Daltons.  
   
   
       7 . The method of  claim 1 , wherein said article comprising cellulose is selected from the group consisting of a bandage, suture, dressing, gauze, gel, foam, web, film, tape, or patch.  
   
   
       8 . The method of  claim 1 , wherein said article comprising cellulose comprises cotton.  
   
   
       9 . The method of  claim 8 , wherein said article comprising cellulose is cotton gauze.  
   
   
       10 . The method of  claim 1 , wherein prior to said application of said hemostatic composition, said active bleeding wound site bleeds at a rate from about 0.5 ml/min to about 1000 ml/min.  
   
   
       11 . The method of  claim 1 , wherein after application of said hemostatic composition, said active bleeding wound site bleeds at a rate of less than 0.03 ml/min.  
   
   
       12 . The method of  claim 11 , wherein said rate of less than 0.03 ml/min is achieved from about 2 to about 20 minutes after application of said hemostatic composition.  
   
   
       13 . The method of  claim 1 , wherein said hemostatic composition further comprises a second polysaccharide covalently linked to said cellulose.  
   
   
       14 . The method of  claim 5 , wherein said hemostatic composition further comprises a second polysaccharide, wherein said second polysaccharide is cross-linked dextran having a molecular weight from about 800,000 to about 2M, wherein said second polysaccharide is covalently linked to said cellulose.  
   
   
       15 . A method for controlling bleeding at an active bleeding wound site of an animal, said method comprising applying a hemostatic composition to said active bleeding wound site, said hemostatic composition comprising an article comprising cellulose in association with ionically cross-linked alginate.  
   
   
       16 . The method according to  claim 15 , wherein said alginate is ionically cross-linked with a cation selected from the group consisting of: Mg2+; Ni2+; Ca2+; Sr2+; Ba2+; Zn2+; Cd2+; Cu2+; Pb2+; Fe3+; and Al3+.  
   
   
       17 . The method according to  claim 15 , further comprising a second polysaccharide covalently linked to said cellulose, wherein said second polysaccharide is cross-linked dextran.  
   
   
       18 . The method according to  claim 17 , wherein said alginate is further covalently linked to said cross-linked dextran.  
   
   
       19 . The method of  claim 1 , wherein said mammal is a human.  
   
   
       20 . The method of  claim 3 , wherein said cross-linked dextran is in the form of beads.

Join the waitlist — get patent alerts

Track US2008020026A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.